IVF INVO Fertility, Inc.
Price Chart
Executive Summary
INVO Fertility reported FY2025 revenue of $6.84M (+5% YoY) and a net loss from continuing operations of $(5.3)M, improving from $(7.7)M in FY2024. The company highlighted a strengthened balance sheet after $11.5M in financing, the acquisition of Family Beginnings, and conversion of all Series C-2 Preferred Stock, but adjusted EBITDA worsened to $(3.2)M from $(2.2)M. Despite operational progress, the stock remains highly speculative with a $2M market cap and negative historical returns on prior calls.
Actionable Insight
The improved loss profile and balance sheet strengthening are positive, but worsening adjusted EBITDA and heavy dilution (shares outstanding surged from ~2,500 to ~1.8M) cap the upside. Monitor Q1 2026 results for organic growth traction and integration of Family Beginnings; the stock's micro-cap status and poor historical T+20 performance suggest high risk.
Key Facts
- FY2025 revenue $6.84M, +5% YoY from $6.53M
- Net loss from continuing operations improved to $(5.3)M from $(7.7)M
- Adjusted EBITDA worsened to $(3.2)M from $(2.2)M
- Completed $11.5M in financing (Dec 2025/Jan 2026) and acquired Family Beginnings clinic
- All Series C-2 Preferred Stock converted or retired; common shares outstanding ~1.8M as of June 2, 2026
- EPS from continuing operations: $(45.57) basic/diluted (FY2025) vs $(3,078.74) in FY2024 (driven by massive share count increase from 2,514 to 117,083 weighted avg shares)
Financial Impact
Revenue growth of ~$309K (+5%) YoY; net loss improved by ~$2.4M; adjusted EBITDA declined by ~$925K; EPS improved from $(3,078.74) to $(45.57) due to share dilution
Risk Factors
- Adjusted EBITDA deterioration despite revenue growth
- Massive share dilution (weighted avg shares from 2,514 to 117,083) obscures true per-share improvement
- Micro-cap ($2M market cap) with low liquidity and negative historical returns on prior analyst calls
- Reliance on continued financing and acquisition pipeline for growth
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3305182 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
3d ago
|
Press Release
| — | awaiting T+1 | — | — |
|
Jun 2, 2026
3d ago
|
8-K
| $1.52 $1.70 | ▲ +11.84% | ▲ +12.54% | $1.59 (+4.61%) |
|
Jun 2, 2026
3d ago
|
8-K
| $1.52 $1.70 | ▼ −11.84% | ▼ −12.54% | $1.59 (−4.61%) |
|
Jun 2, 2026
3d ago
|
Press Release
| $1.52 $1.70 | ▲ +11.84% | ▲ +12.54% | $1.59 (+4.61%) |
|
Mar 3, 2026
13w ago
|
Press Release
| $4.33 $4.44 | ▲ +2.54% | ▲ +1.78% | $1.59 (−63.24%) |
|
Feb 24, 2026
14w ago
|
8-K
| $5.00 $4.97 | ▼ −0.50% | ▼ −1.33% | $1.59 (−68.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access